Very low rates of culture-confirmed invasive bacterial infections in a prospective 3-year population-based surveillance in Southwest London

K. Le Doare,A.-L. Nichols,H. Payne,R. Wells,S. Navidnia,G. Appleby,E. Calton,M. Sharland,S. N. Ladhani,A. Irwin,L. Segal,P. Riley,J. Handforth,R. El Rifai,R. Heath,S. Luck,

DOI: https://doi.org/10.1136/archdischild-2013-305565

2014-02-19

Archives of Disease in Childhood

Abstract:OBJECTIVES: To estimate the incidence, clinical characteristics and risk factors for culture-confirmed invasive bacterial infections in England.DESIGN: Prospective, observational, study of all children with positive blood and/or cerebrospinal fluid (CSF) culture over a 3-year period (2009-2011).SETTING: All five hospitals within a geographically defined region in southwest London providing care for around 600 000 paediatric residents.PATIENTS: Children aged 1 month to 15 yearsMAIN OUTCOME MEASURES: Rates of community-acquired and hospital-acquired invasive bacterial infections in healthy children and those with co-morbidities; pathogens by age group, risk group and clinical presentation.RESULTS: During 2009-2011, 44 118 children had 46 039 admissions, equivalent to 26 admissions per 1000 children. Blood/CSF cultures were obtained during 44.7% of admissions, 7.4% were positive but only 504 were clinically significant, equivalent to 32.9% of positive blood/CSF cultures, 2.4% of all blood/CSF cultures and 1.1% of hospital admissions. The population incidence of culture-confirmed invasive bacterial infection was 28/100 000. One-third of infections were hospital acquired and, of the community-acquired infections, two-thirds occurred in children with pre-existing co-morbidities. In previously healthy children, therefore, the incidence of community-acquired invasive bacterial infection was only 6.4/100 000.CONCLUSIONS: Although infection was suspected in almost half the children admitted to hospital, a significant pathogen was cultured from blood or CSF in only 2.4%, mainly among children with pre-existing co-morbidities, who may require a more broad-spectrum empiric antibiotic regime compared to previously healthy children. Invasive bacterial infection in previously healthy children is now very rare. Improved strategies to manage low-risk febrile children are required.

pediatrics